QURE Options Flow Analysis: Gene Therapy Moonshot with 214% Implied Volatility
Massive $18M institutional bet on gene therapy breakthrough. Smart money positioning ahead of critical FDA catalysts that could send this biotech moonshot. Full breakdown reveals the binary catalyst setup and three risk-adjusted plays.
This post is for paying subscribers only
Already have an account? Sign in.